Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 USD | +3.10% | +4.10% | -85.50% |
Apr. 16 | Barnes & Noble Education to Receive $95 Million Investment, Adopts Short-Term Poison Pill; Shares Plunge | MT |
Apr. 16 | Barnes & Noble Education Adopts Short-Term Poison Pill | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-85.50% | 11.48M | C+ | ||
-18.14% | 1.77B | B | ||
+50.44% | 220M | - | ||
+54.30% | 69.02M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BNED Stock
- Ratings Barnes & Noble Education, Inc.